DP VII ASSOCIATES LP

CIK 000137293211 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001372932

Recent Transactions

50 trades

Disposition from Tender
Tobira Therapeutics, Inc.
Common Stock
2016-11-01$28.35/sh−47,613→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Common Stock
2016-10-12+49,570→ 49,570 total
Conversion
Vyome Holdings, Inc$HIND
Series B Preferred Stock
2016-10-12−20,583→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Series A Preferred Stock
2016-10-12−11,083→ 0 total
Conversion
Vyome Holdings, Inc$HIND
Series C Preferred Stock
2016-10-12−14,271→ 0 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-05-26$4.70/sh−5,880→ 10,328 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-27$5.02/sh−61→ 16,208 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-25$5.20/sh−21→ 16,269 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-20$5.29/sh−76→ 16,290 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-19$5.36/sh−632→ 16,366 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-11$5.22/sh−75→ 16,998 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-08$5.35/sh−251→ 17,073 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-07$5.26/sh−475→ 17,324 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2016-04-06$5.22/sh−148→ 17,799 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-08-18$7.02/sh−202→ 17,947 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-04-16$7.07/sh−554→ 18,149 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-04-15$7.58/sh−135→ 18,703 total
Sale
Evoke Pharma Inc$EVOK
Common Stock
2015-04-14$7.78/sh−168→ 18,838 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock
2014-11-25−36,913→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock Warrant (Right to Buy)
2014-11-25−2,827→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock
2014-11-25−102,282→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series A Preferred Stock
2014-11-25−12,578→ 0 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−958→ 46,921 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−1,725→ 48,023 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock Warrant (Right to Buy)
2014-11-25−2,827→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B Preferred Stock
2014-11-25−104,247→ 0 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−1,725→ 48,025 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock
2014-11-25−36,913→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock Warrant (Right to Buy)
2014-11-25−1,570→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Series B-2 Preferred Stock Warrant (Right to Buy)
2014-11-25−1,570→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+1,570→ 47,881 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series B Preferred Stock
2014-11-25−104,247→ 0 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+1,570→ 47,879 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+2,827→ 49,750 total
Tax Payment
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$14.00/sh−958→ 46,923 total
Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25+46,311→ 46,311 total
Exercise/Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25$8.54/sh+2,827→ 49,748 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series C Preferred Stock
2014-11-25−102,282→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Series A Preferred Stock
2014-11-25−12,578→ 0 total
Conversion
Evofem Biosciences, Inc.$EVFM
Common Stock
2014-11-25+46,309→ 46,309 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
Common Stock
2014-03-19$14.00/sh−50,743→ 0 total
Conversion
Achaogen, Inc.
Series C Preferred Stock
2014-03-17−15,799→ 0 total
Conversion
Achaogen, Inc.
Series B Preferred Stock
2014-03-17−10,661→ 0 total
Conversion
Achaogen, Inc.
Common Stock
2014-03-17+33,890→ 33,890 total
Conversion
Achaogen, Inc.
Series D Preferred Stock
2014-03-17−7,430→ 0 total
Exercise/Conversion
CADENCE PHARMACEUTICALS INC
Common Stock
2014-02-12$7.84/sh+23,317→ 63,801 total
Tax Payment
CADENCE PHARMACEUTICALS INC
Common Stock
2014-02-12$14.00/sh−13,058→ 50,743 total
Exercise/Conversion
CADENCE PHARMACEUTICALS INC
Warrants to Purchase Common Stock
2014-02-12−23,317→ 0 total
Conversion
TANDEM DIABETES CARE INC$TNDM
Common Stock
2013-11-19+54,390→ 54,390 total
Other
TANDEM DIABETES CARE INC$TNDM
Warrant to Purchase Series D Preferred Stock
2013-11-19−10,068→ 0 total

DP VII ASSOCIATES LP

Recent Transactions

Companies

Recent Filings

Address